DEFINING CLINICALLY ACTIONABLE SUBTYPES OF CASTRATION RESISTANT PROSTATE CANCER THROUGH EPIGENETIC CELL-FREE DNA ANALYSIS

$1,382,551FY2025Defense Health AgencyDOD

Emory University, Atlanta GA

Investigators